Last updated on September 2019

Atopic Dermatitis

Brief description of study

A randomised, double-blind, placebo-controlled trial to evaluate the effect of tralokinumab on vaccine antibody responses in adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.


Clinical Study Identifier: TX210461

Find a site near you

Start Over

Direct Helpers Research Center

425 W 51st Place Hialeah, Florida United States
  Connect »